FDA Halts Juno’s Phase 2 ROCKET Trial in Lymphoblastic Leukemia Patients
News
Juno Therapeutics announced that the U.S. Food and Drug Administration (FDA) has placed a clinical hold on the Phase 2 ROCKET clinical trial of JCAR015 in adult patients with relapsed/refractory B-cell ... Read more